Saturday, 21 April 2012

Registration Status of Benlysta® (belimumab) in Australia - GlaxoSmithKline Australia

Registration Status of Benlysta® (belimumab) in Australia - GlaxoSmithKline Australia:

'via Blog this'

According to GlaxoSmithKline Australia (see link above), their application for Benlysta to be approved for treatment of lupus patients in Australia has been rejected by the Therapeutic Goods Administration. GSK is currently appealing the decision.

You might recall that there were petitions in Britain to try to have the British decision to not allow the use of Benlysta there overturned. I understand there may be a petition being circulated here in Australia soon, I will let you know as soon as I know about it.
Posted by at
Reactions: 
Labels: ,

2 comments:

  1. natalie9 May 2012 at 22:13

    I am looking forward for the updates since my mother is a lupus patient.printing hervey bay

    ReplyDelete
    Replies
    1. Iris Carden11 May 2012 at 11:15

      I hope we have good news on this some time soon!

      Delete

Thanks for being part of the conversation.

Your comment will be visible after moderation.

Subscribe to: Post Comments (Atom)